GeneDx Holdings (WGS) Earnings Analysis

GeneDx Holdings (WGS) next reports earnings on 2026-08-03, consensus EPS -0.19 USD. Last quarter (2026-05-04) it missed with EPS -0.28 USD vs -0.06 USD est (-366.7%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -23.53.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does WGS next report earnings?

Next earnings date2026-08-03
Consensus EPS estimate-0.19 USD
Revenue estimate0.11B

WGS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-04-0.28 USD-0.06 USD-366.7%Miss
2026-02-230.14 USD0.11 USD+27.3%Beat
2025-04-300.28 USD0.11 USD+154.5%Beat
2025-02-180.7 USD0.04 USD+1650%Beat

Beat rate: 3/4 (75%) over reported quarters with consensus data.

WGS valuation and analyst view

Trailing P/E-23.53
Trailing EPS-2.65238 USD
Price / book7.23
Dividend yield0.00%
Market cap1.83B
Analyst consensusBuy (10 buy / 1 hold / 0 sell)
Avg price target76 USD

Related research pages

Frequently asked questions

When is GeneDx Holdings (WGS)'s next earnings date?

GeneDx Holdings is next scheduled to report on 2026-08-03, with a consensus EPS estimate of -0.19 USD and revenue estimate of 0.11B.

Did WGS beat earnings last quarter?

In its 2026-05-04 report, WGS posted EPS of -0.28 USD versus a -0.06 USD estimate — a miss of 366.7%.

What is WGS's earnings track record?

Over the last 4 reported quarters with consensus data, WGS beat estimates 3 times (75%).

What is WGS's current P/E ratio and EPS?

WGS trades at a trailing P/E of -23.53 on trailing EPS of -2.6523833577534317 USD.

What do analysts rate WGS?

Analyst consensus is "Buy" across 11 ratings (0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 76 USD.